Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repurposing Lithium as a Disease-modifying Therapy in Parkinson's Disease: A Phase I Trial

NCT06099886 is registered in ClinicalTrials.gov with State University of New York at Buffalo as lead sponsor.

NCT NCT06099886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06099886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repurposing Lithium as a Disease-modifying Therapy in Parkinson's Disease: A Phase I Trial
Lead sponsor
State University of New York at Buffalo
Phase
Phase 1
Overall status
Completed
Start date
October 12, 2023
Completion date
April 30, 2025
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease